Literature DB >> 28467828

Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.

Joshua D Ooi1, Jan Petersen2,3, Yu H Tan2, Megan Huynh1, Zoe J Willett1, Sri H Ramarathinam2, Peter J Eggenhuizen1, Khai L Loh2, Katherine A Watson4, Poh Y Gan1, Maliha A Alikhan1, Nadine L Dudek2, Andreas Handel5, Billy G Hudson6, Lars Fugger7, David A Power8,9, Stephen G Holt9,10, P Toby Coates11, Jon W Gregersen12, Anthony W Purcell2, Stephen R Holdsworth1,13, Nicole L La Gruta2,4, Hugh H Reid2,3, Jamie Rossjohn2,3,14, A Richard Kitching1,13,15,16.   

Abstract

Susceptibility and protection against human autoimmune diseases, including type I diabetes, multiple sclerosis, and Goodpasture disease, is associated with particular human leukocyte antigen (HLA) alleles. However, the mechanisms underpinning such HLA-mediated effects on self-tolerance remain unclear. Here we investigate the molecular mechanism of Goodpasture disease, an HLA-linked autoimmune renal disorder characterized by an immunodominant CD4+ T-cell self-epitope derived from the α3 chain of type IV collagen (α3135-145). While HLA-DR15 confers a markedly increased disease risk, the protective HLA-DR1 allele is dominantly protective in trans with HLA-DR15 (ref. 2). We show that autoreactive α3135-145-specific T cells expand in patients with Goodpasture disease and, in α3135-145-immunized HLA-DR15 transgenic mice, α3135-145-specific T cells infiltrate the kidney and mice develop Goodpasture disease. HLA-DR15 and HLA-DR1 exhibit distinct peptide repertoires and binding preferences and present the α3135-145 epitope in different binding registers. HLA-DR15-α3135-145 tetramer+ T cells in HLA-DR15 transgenic mice exhibit a conventional T-cell phenotype (Tconv) that secretes pro-inflammatory cytokines. In contrast, HLA-DR1-α3135-145 tetramer+ T cells in HLA-DR1 and HLA-DR15/DR1 transgenic mice are predominantly CD4+Foxp3+ regulatory T cells (Treg cells) expressing tolerogenic cytokines. HLA-DR1-induced Treg cells confer resistance to disease in HLA-DR15/DR1 transgenic mice. HLA-DR15+ and HLA-DR1+ healthy human donors display altered α3135-145-specific T-cell antigen receptor usage, HLA-DR15-α3135-145 tetramer+ Foxp3- Tconv and HLA-DR1-α3135-145 tetramer+ Foxp3+CD25hiCD127lo Treg dominant phenotypes. Moreover, patients with Goodpasture disease display a clonally expanded α3135-145-specific CD4+ T-cell repertoire. Accordingly, we provide a mechanistic basis for the dominantly protective effect of HLA in autoimmune disease, whereby HLA polymorphism shapes the relative abundance of self-epitope specific Treg cells that leads to protection or causation of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28467828      PMCID: PMC5903850          DOI: 10.1038/nature22329

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  37 in total

1.  A Systems Approach to Understand Antigen Presentation and the Immune Response.

Authors:  Nadine L Dudek; Nathan P Croft; Ralf B Schittenhelm; Sri H Ramarathinam; Anthony W Purcell
Journal:  Methods Mol Biol       Date:  2016

2.  The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra.

Authors:  Ignat V Shilov; Sean L Seymour; Alpesh A Patel; Alex Loboda; Wilfred H Tang; Sean P Keating; Christie L Hunter; Lydia M Nuwaysir; Daniel A Schaeffer
Journal:  Mol Cell Proteomics       Date:  2007-05-27       Impact factor: 5.911

3.  Healthy individuals have Goodpasture autoantigen-reactive T cells.

Authors:  Juan Zou; Sigrid Hannier; Lindsay S Cairns; Robert N Barker; Andrew J Rees; A Neil Turner; Richard G Phelps
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

4.  A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides.

Authors:  R B Schittenhelm; N L Dudek; N P Croft; S H Ramarathinam; A W Purcell
Journal:  Tissue Antigens       Date:  2014-01-07

5.  HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis.

Authors:  I E van der Horst-Bruinsma; H Visser; J M Hazes; F C Breedveld; W Verduyn; G M Schreuder; R R de Vries; E Zanelli
Journal:  Hum Immunol       Date:  1999-02       Impact factor: 2.850

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease.

Authors:  Alan D Salama; Afzal N Chaudhry; Kathryn A Holthaus; Karen Mosley; Raghu Kalluri; Mohamed H Sayegh; Robert I Lechler; Charles D Pusey; Liz Lightstone
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

8.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

9.  Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans.

Authors:  Timothy J Aitman; Rong Dong; Timothy J Vyse; Penny J Norsworthy; Michelle D Johnson; Jennifer Smith; Jonathan Mangion; Cheri Roberton-Lowe; Amy J Marshall; Enrico Petretto; Matthew D Hodges; Gurjeet Bhangal; Sheetal G Patel; Kelly Sheehan-Rooney; Mark Duda; Paul R Cook; David J Evans; Jan Domin; Jonathan Flint; Joseph J Boyle; Charles D Pusey; H Terence Cook
Journal:  Nature       Date:  2006-02-16       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  74 in total

1.  Autoimmunity: HLA-mediated protection in Goodpasture disease.

Authors:  Ellen F Carney
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

2.  Autoimmunity: HLA-mediated protection in Goodpasture disease.

Authors:  Ellen F Carney
Journal:  Nat Rev Rheumatol       Date:  2017-05-18       Impact factor: 20.543

3.  TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells.

Authors:  Itay Raphael; Francisco Gomez-Rivera; Rebecca A Raphael; Rachel R Robinson; Saisha Nalawade; Thomas G Forsthuber
Journal:  JCI Insight       Date:  2019-12-19

Review 4.  Natural and Induced Tolerogenic Dendritic Cells.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  J Immunol       Date:  2020-02-15       Impact factor: 5.422

5.  PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.

Authors:  Ryan Galea; Hendrik J Nel; Meghna Talekar; Xiao Liu; Joshua D Ooi; Megan Huynh; Sara Hadjigol; Kate J Robson; Yi Tian Ting; Suzanne Cole; Karyn Cochlin; Shannon Hitchcock; Bijun Zeng; Suman Yekollu; Martine Boks; Natalie Goh; Helen Roberts; Jamie Rossjohn; Hugh H Reid; Ben J Boyd; Ravi Malaviya; David J Shealy; Daniel G Baker; Loui Madakamutil; A Richard Kitching; Brendan J O'Sullivan; Ranjeny Thomas
Journal:  JCI Insight       Date:  2019-09-19

6.  Experimental Antiglomerular Basement Membrane GN Induced by a Peptide from Actinomyces.

Authors:  Qiu-Hua Gu; Megan Huynh; Yue Shi; Xiao-Yu Jia; Jie-Jian Luo; Tai-Jiao Jiang; Zhao Cui; Joshua D Ooi; A Richard Kitching; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2020-06       Impact factor: 10.121

Review 7.  Dendritic Cells As Inducers of Peripheral Tolerance.

Authors:  Courtney A Iberg; Andrew Jones; Daniel Hawiger
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

Review 8.  Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney disease.

Authors:  Stephen R Holdsworth; A Richard Kitching
Journal:  Nat Rev Nephrol       Date:  2017-12-18       Impact factor: 28.314

9.  Increased islet antigen-specific regulatory and effector CD4+ T cells in healthy individuals with the type 1 diabetes-protective haplotype.

Authors:  Xiaomin Wen; Junbao Yang; Eddie James; I-Ting Chow; Helena Reijonen; William W Kwok
Journal:  Sci Immunol       Date:  2020-02-14

10.  Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Antonis K Moustakas; George P Bondinas; Annelie Carlsson; Helena Elding Larsson; Johnny Ludvigsson; Claude Marcus; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.